CDT
CDT Equity Inc.NASDAQHealthcare$3.95+0.00%ClosedMarket Cap: $698,514
As of 2026-04-07
Valuation
P/E (TTM)
0.00
PEG
0.00
P/B
0.00
P/S
0.00
EV/EBITDA
12.50
DCF Value
$1,999,073.60
FCF Yield
31308.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
36.5%
Operating Margin
43.8%
Net Margin
33.0%
ROE
74.5%
ROA
6.7%
ROIC
11.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $720.1M | 36.6% | $331.3M | $255.4M | $425.00 | — |
| FY 2025 | $2.72B | 38.0% | $315.7M | $237.5M | $1,477.50 | — |
| Q3 2025 | $0.00 | -Infinity% | $-7.0M | $-7.1M | $1,000.00 | — |
| Q2 2025 | $0.00 | NaN% | $-5.0M | $-6.0M | $382.50 | — |
| Q1 2025 | $0.00 | NaN% | $-3.6M | $-4.8M | $-330.00 | — |
| Q4 2024 | $0.00 | -Infinity% | $-3.5M | $-2.4M | $-5,400.00 | — |
| FY 2024 | $0.00 | -Infinity% | $-15.4M | $-17.8M | $-5,132.50 | — |
| Q3 2024 | $0.00 | -Infinity% | $-5.8M | $-6.5M | $325.00 | — |
| Q2 2024 | $0.00 | NaN% | $-3.1M | $-5.4M | $-27,332.50 | — |
| Q1 2024 | $0.00 | NaN% | $-3.0M | $-3.6M | $27,275.00 | — |
| Q4 2023 | $0.00 | NaN% | $-895.0K | $1.8M | $-152.50 | — |
| FY 2023 | $0.00 | NaN% | $-5.3M | $-535.0K | $-900.00 | — |